Outset Medical (OM) Stock Analysis & AI Equity Report
Outset Medical (OM) overview
Outset Medical (OM) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 119m and operating profit of USD -66.7m; the year-end share price was 3.71 USD and market capitalisation was USD 67.4m. Outset Medical is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Outset Medical's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
About Outset Medical
Outset Medical develops and sells the Tablo Hemodialysis System, a compact dialysis console with integrated water purification, on-demand dialysate production, touchscreen controls, and connected software. Cleared for use in hospitals, clinics, and homes, Tablo supports dialysis across care settings. The company also provides providers with training, service, data analytics, electronic health record integration, and clinical support.
Generate the Outset Medical report
Outset Medical is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Outset Medical and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Analyst reports on Outset Medical
Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.